Đang chuẩn bị liên kết để tải về tài liệu:
Predictors of breast cancer cell types and their prognostic power in breast cancer patients

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

In this study, we explore scRNASeq cancer data from a different perspective. We focus on scRNASeq data originating from cancer cells pertaining to a particular cancer type, where the cell type or the subpopulation to which each cell belongs is known. We investigate if the “cell type” of a cancer cell can be predicted based on the expression profiles of a small set of transcripts. |

TÀI LIỆU LIÊN QUAN

A germline mutation in the BRCA1 3’UTR predicts Stage IV breast cancer

ANGPTL4 overexpression inhibits tumor cell adhesion and migration and predicts favorable prognosis of triple-negative breast cancer

A prognostic model based on cell-cycle control predicts outcome of breast cancer patients

Long non-coding RNA BRE-AS1 inhibits the proliferation, migration, and invasion of cancer cells in triple-negative breast cancer and predicts patients’ survival by downregulating miR-21

Parkin gene mutations are not common, but its epigenetic inactivation is a frequent event and predicts poor survival in advanced breast cancer patients

Decelerated DNA methylation age predicts poor prognosis of breast cancer

Overexpression of prostate tumor overexpressed 1 correlates with tumor progression and predicts poor prognosis in breast cancer

Overexpression of synuclein-γ predicts lack of benefit from radiotherapy for breast cancer patients

High baseline Tie1 level predicts poor survival in metastatic breast cancer

Stromal ColXα1 expression correlates with tumor-infiltrating lymphocytes and predicts adjuvant therapy outcome in ER-positive/ HER2-positive breast cancer
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.